Financhill
Back

Biogen 10K Form

Sell
36

BIIB
Biogen

Last Price:
230.10
Seasonality Move:
4.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIIB News And Ratings

See the #1 stock for the next 7 days that we like better than BIIB

BIIB Financial Statistics

Sales & Book Value

Annual Sales: $9.84B
Cash Flow: $432.3M
Price / Cash Flow: 26.07
Annual Sales: $105.06
Price / Book: 2.2

Profitability

EPS (TTM): 8.01000
Net Income (TTM): $1.17B
Gross Margin: $7.3B
Return on Equity: 8.02%
Return on Assets: 4.44%

Biogen Earnings Forecast

Key Biogen Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIIB is 74.24%.
  • The Selling, General & Administrative Expenses for BIIB have been equal to 25.92% of Gross Profit Margin.
  • The Research & Development expenses have been 25.03% of Revenue.
  • The Interest Expense is 21.26% of Operating Income.
  • The Net Earning history of BIIB is 11.81% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Biogen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: BIIB
CUSIP: 09062X
Website: biogen.com

Debt

Debt-to-Equity Ratio: 0.43
Current Ratio: 2.1
Quick Ratio: 0.95

Price-to-Earnings

Trailing P/E Ratio: 28.87
Forward P/E Ratio: 13.41

BIIB Technical Analysis vs Fundamental Analysis

Sell
36
Biogen (BIIB) is a Sell

Is Biogen a Buy or a Sell?

  • Biogen stock is rated a Sell
    The current Biogen [BIIB] share price is $230.06. The Score for BIIB is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.